Literature DB >> 2708231

Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects.

O Michel1, J Duchateau, R Sergysels.   

Abstract

Endotoxins are released from the membrane of Gram-negative bacteria present in the environment and in oral and nasal cavities. They are proinflammatory substances that could participate in bronchial obstruction and hyperreactivity in asthmatic patients. This hypothesis was tested by using bronchial challenge tests with inhaled lipopolysaccharides (LPS) from Escherichia coli 026:B6 (22.2-micrograms total dose) followed by a histamine nonspecific challenge test and compared with a placebo procedure, in which the diluent was substituted for the LPS solution. In doing so we showed that LPS induces a slight but significant (P less than 0.01) bronchial obstruction (measured as forced expiratory volume in 1 s) in asthmatics (n = 8) but not in normal subjects (n = 6). The histamine hyperresponsiveness, expressed as the dosage of histamine necessary to decrease the bronchial specific conductance by 50%, was increased 5 h after LPS inhalation in asthmatics (P less than 0.05) but not in normal subjects. This effect of LPS on bronchial obstruction and hyperresponsiveness was observed in extrinsic (n = 6) as well as in intrinsic (n = 2) asthma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708231     DOI: 10.1152/jappl.1989.66.3.1059

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  51 in total

Review 1.  Does environmental endotoxin exposure prevent asthma?

Authors:  J Douwes; N Pearce; D Heederik
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects.

Authors:  Raminder Aul; Jane Armstrong; Annelyse Duvoix; David Lomas; Brian Hayes; Bruce E Miller; Chris Jagger; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

3.  Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers.

Authors:  Michelle L Hernandez; Margaret Herbst; John C Lay; Neil E Alexis; Willie June Brickey; Jenny P Y Ting; Haibo Zhou; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2012-07-04       Impact factor: 10.793

4.  Change in airway responsiveness over a workweek in organic waste loaders.

Authors:  Gea de Meer; Dick Heederik; Inge M Wouters
Journal:  Int Arch Occup Environ Health       Date:  2007-01-06       Impact factor: 3.015

Review 5.  Allergen-specific pattern recognition receptor pathways.

Authors:  Marsha Wills-Karp
Journal:  Curr Opin Immunol       Date:  2010-11-17       Impact factor: 7.486

6.  Comparison of the Effect of Ribosomal Immunotherapy on Plasma Levels of Total IgE and Cytokines IL-4, IL-5, IL-12 and IFNgamma in Adult Atopic and Non-Atopic Patients during the Pollen Season.

Authors:  J Bystron; Z Hermanová; J Szotkovská; L Heller; D Pazderová
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  Reproducibility of a novel model of murine asthma-like pulmonary inflammation.

Authors:  L McKinley; J Kim; G L Bolgos; J Siddiqui; D G Remick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  Effect of tumor necrosis factor receptor binding protein on cell infiltration induced by lipopolysaccharide and Sephadex beads in guinea pig lung.

Authors:  D M Conroy; J N Francischi; P Sirois
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

9.  Endotoxin augments myeloid dendritic cell influx into the airways in patients with allergic asthma.

Authors:  Frank Schaumann; Meike Müller; Armin Braun; Birgit Luettig; David B Peden; Jens M Hohlfeld; Norbert Krug
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

10.  Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects.

Authors:  J A Nightingale; D F Rogers; L A Hart; S A Kharitonov; K F Chung; P J Barnes
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.